Roivant Sciences Founder Ramaswamy to Sell $6.6M in Stock Holdings

Roivant Sciences Form 144 filing reveals significant insider stock sales by Vivek Ramaswamy, indicating planned disposal of 577,007 shares with an aggregate market value of $6,611,850.

Rhea-AI Filing Summary

Roivant Sciences Form 144 filing reveals significant insider stock sales by Vivek Ramaswamy, indicating planned disposal of 577,007 shares with an aggregate market value of $6,611,850. The sale is scheduled for June 20, 2025, through Rockefeller Financial LLC on NASDAQ.

Key transaction details:

• Securities originated as Founder Shares acquired on May 7, 2014
• Total outstanding shares: 679,806,070
• Recent trading activity shows substantial sales in past 3 months totaling 2,212,455 shares for approximately $25 million

Previous sales by Ramaswamy in the last 3 months occurred on multiple dates:

• June 18: 565,266 shares ($6.47M)
• June 6: 200,800 shares ($2.25M)
• June 4: 547,430 shares ($6.21M)
• May 7: 625,000 shares ($6.99M)
• May 6: 273,959 shares ($3.14M)

Positive

• None.

Negative

• Founder and former CEO Vivek Ramaswamy has sold approximately 2.21 million shares worth over $25M in the past 3 months, indicating significant insider selling pressure
• The planned sale of an additional 577,007 shares ($6.61M) continues the substantial liquidation pattern
• Total insider sales represent a material reduction in Ramaswamy's founder holdings, potentially signaling decreased confidence in company prospects

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ROIV shares is Vivek Ramaswamy selling according to the June 2025 Form 144?

According to the Form 144 filing, Vivek Ramaswamy plans to sell 577,007 shares of ROIV common stock through Rockefeller Financial LLC, with an aggregate market value of $6,611,850.11.

What is the total value of ROIV shares sold by Vivek Ramaswamy in the past 3 months before June 2025?

In the three months prior to the filing, Vivek Ramaswamy sold a total of 2,212,455 shares of ROIV common stock for total gross proceeds of approximately $25,057,989.92 across five separate transactions between May and June 2025.

When did Vivek Ramaswamy originally acquire his ROIV shares being sold?

According to the filing, Vivek Ramaswamy acquired 58,409,211 shares on May 7, 2014, as Founder Shares from Roivant Sciences Ltd.

What percentage of ROIV's outstanding shares is Ramaswamy planning to sell?

The planned sale of 577,007 shares represents approximately 0.085% of ROIV's total outstanding shares, which according to the filing is 679,806,070 shares.

What was the largest single ROIV stock sale by Ramaswamy in the past 3 months?

The largest single sale was 625,000 shares on May 7, 2025, which generated gross proceeds of $6,987,387.60.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 04:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001635075
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Roivant Sciences Ltd.
SEC File Number	001-40782
Address of Issuer	7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM SW1H 0DB
Phone	441-295-5950
Name of Person for Whose Account the Securities are To Be Sold	Ramaswamy Vivek
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York City NY 10111	577007	6611850.11	679806070	06/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2014	Founder Shares	Roivant Sciences Ltd.			58409211	05/07/2014	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	05/06/2025	273959	3143286.58
Vivek Ramaswamy 7th floor, 50th Broadway London X0 SW1H 0DB	Common	05/07/2025	625000	6987387.60
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	06/04/2025	547430	6208008.15
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	06/06/2025	200800	2246311.26
Vivek Ramaswamy 7th floor, 50th Broadway London X0 SW1H 0DB	Common	06/18/2025	565266	6472996.33

144: Remarks and Signature

Remarks
Date of Notice	06/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Ramaswamy Vivek
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)